Trillium Therapeutics Inc. (TRIL.TO) and trades at $23.33. The 52-week range is 23.22-23.45.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -33.3, Earnings Per Share (EPS) of $-0.70, annual revenue of $148K.
The stock has a beta of 1.90, operates in the Healthcare sector.
